Effectiveness and safety of Selective serotonin Reuptake inhibitor (SSRI) alone vsSSRI with Methylphenidate sustained release in the patients with moderate to severe obsessive compulsive disorder(OCD) - nil

MGM Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Patients with OCD disorder who fulfill the diagnostic criteria according to DSM-5.
•Patient with Total score more than 16 in Yale-Brown obsessive-compulsive disorder scale.
•Patients aged between 18-85 years.
•Subjects who Provide written informed consent, willing and able to comply with all aspects of the protocol

•Patient with prior allergic reaction on exposure to Methylphenidate
•OCD patients with psychiatric illness except depression and anxiety
•Substance abuse or Dependence within the past 6 months except nicotine
•History of a seizure disorder or other major neurologic disease.
•Patients with psychiatric Instability that made participants potentially unsafe in the evaluating psychiatrists judgment.
•Patients with pregnancy or breastfeeding
•Patients with known chronic medical illness like, Diabetes Mellitus, Hypertension, Cerebro-vascular Accident, Ischemic Heart Disease, Coronary Artery Disease etc.
•Patients not in a condition to give written informed consent E.g.: Delirium, intellectual disability etc.

发起方